측두하악 관절원판 후조직의 MMP(matrix metalloproteinase)-1과 MMP-2 mRNA의 발현

EXPRESSION OF MATRIX METALLOPROTEINASE-1 AND -2 MRNA IN RETRODISCAL TISSUE OF THE TEMPOROMANDIBULAR JOINT

  • 허종기 (연세대학교 치과대학 구강악안면외과학교실(용인세브란스병원)) ;
  • 박광균 (연세대학교 치과대학 구강생물학교실) ;
  • 최민아 (연세대학교 치과대학 구강생물학교실) ;
  • 김형곤 (연세대학교 치과대학 구강악안면외과학교실(영동세브란스병원))
  • Huh, Jong-Ki (Dept. of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University(Yongin Severance Hospital)) ;
  • Park, Kwang-Kyun (Dept. of Oral Biology, College of Dentistry, Yonsei University) ;
  • Choi, Min-Ah (Dept. of Oral Biology, College of Dentistry, Yonsei University) ;
  • Kim, Hyung-Gon (Dept. of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University(Yongdong Severance Hospital))
  • 발행 : 2003.08.31

초록

Matrix metalloproteinases (MMPs) play an important role in the normal morphogenesis, maintenance, and repair of matrix and also have important functions in pathologic conditions characterized by excessive degradation of extracellular matrix, such as rheumatoid arthritis, osteoarthritis, periodontitis and in tumor invasion and metastasis. In this study, expression of MMP-1 and -2 mRNA in retrodiscal tissue of the temporomandibular joint (TMJ) was examined and compared with magnetic resonance imaging (MRI) and surgical findings. MMP mRNAs in the retrodiscal tissue samples were detected by reverse transcription - polymerase chain reaction. TMJ internal derangement (ID) was categorized as normal disc position, disc displacement with reduction, early stage of disc displacement without reduction (DDsR) and late stage of DDsR. TMJ osteoarthrosis (OA) was classified with normal, mild and advanced OA. The amount of synovial fluid collection was divided into not detected, small, large and extremely large amount on MR T2-weighted imaging. Perforation and adhesion were examined during open surgery of the TMJ. Six out of 37 samples were excluded because of little amount of extracted total mRNA. MMP-2 mRNA was detected whole joints, and so the MMP-2 mRNA seems to be expressed normally in retrodiscal tissue. However, MMP-1 mRNA was expressed in 8 of 31 joints. Frequencies of MMP-1 mRNA expression according to the TMJ IDs, amount of synovial fluid and surgical findings made no significant difference. MMP-1 mRNA was detected more frequently in OA groups (7/16 joints, 43.8%) than in normal bony structure group (1/15 joints, 6.7%). Expression of MMP-1 mRNA in retrodiscal tissue might be related with OA of the TMJ.

키워드

참고문헌

  1. Woessner JF Jr. The matrix metalloproteinase family. In: Parks WC, Mecham RP. Matrix metalloproteinases. San Diego, Academic Press, 1998;1-14.
  2. Kubota T, Kubota E, Matsumoto A, Kawai Y, Saito H, Mikuni-Takagaki Y, Sato S: Identification of matrix metalloproteinases (MMPs) in synovial fluid from patients with temporomandibular disorder. Eur J Oral Sci 1998;106:992-998. https://doi.org/10.1046/j.0909-8836.1998.eos106603.x
  3. Mizui T, Ishimaru JI, Miyamoto K, Kurita K: Matrix metalloproteinase-2 in synovial lavage fluid of patients with disorders of the temporomandibular joint. Br J Oral Maxillofac Surg 2001;39:310-314. https://doi.org/10.1054/bjom.2001.0634
  4. Srinivas R, Sorsa T, Tjaderhane L, Niemi E, Raustia A, Pernu H, Teronen O, Salo T: Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91:517-525. https://doi.org/10.1067/moe.2001.115136
  5. Tanaka A, Kawashiri S, Kumagai S, Takatsuka S, Narinobou M, Nakagawa K, Tanaka S: Expression of matrix metalloproteinase-2 in osteoarthritic fibrocartilage from human mandibular condyle. J Oral Pathol Med 2000;29:314-320. https://doi.org/10.1034/j.1600-0714.2000.290705.x
  6. Tanaka A, Kumagai S, Kawashiri S, Takatsuka S, Nakagawa K, Yamamoto E, Matsumoto N: Expression of matrix metalloproteinase-2 and -9 in synovial fluid of the temporomandibular joint accompanied by anterior disc displacement. J Oral Pathol Med 2001;30:59-64. https://doi.org/10.1034/j.1600-0714.2001.300110.x
  7. Kanyama M, Kuboki T, Kojima S, Fujisawa T, Hattori T, Takigawa M, Yamashita A: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis. J Orofac Pain 2000;14:20-30.
  8. Kubota E, Imamura H, Kubota T, Shibata T, Murakami K: Interleukin 1 beta and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 1997;55:20-27. https://doi.org/10.1016/S0278-2391(97)90438-9
  9. Kubota E, Kubota T, Matsumoto J, Shibata T, Murakami KI: Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. J Oral Maxillofac Surg 1998;56:192-198. https://doi.org/10.1016/S0278-2391(98)90868-0
  10. Woessner JF, Nagase H. Protein substrates of the MMPs. In: Woessner JF, Nagase H. Matrix metalloproteinases and TIMPs. New York, Oxford University Press, 2000;87-97.
  11. Gage JP, Virdi AS, Triffitt JT, Howlett CR, Francis MJ: Presence of type III collagen in disc attachments of human temporomandibular joints. Arch Oral Biol 1990;35:283-288. https://doi.org/10.1016/0003-9969(90)90044-B
  12. Mills DK, Fiandaca DJ, Scapino RP: Morphologic, microscopic, and immunohistochemical investigations into the function of the primate TMJ disc. J Orofac Pain 1994;8:136-154.
  13. Nagy NB, Daniel JC: Distribution of elastic fibres in the developing rabbit craniomandibular joint. Arch Oral Biol 1991;36:15-23. https://doi.org/10.1016/0003-9969(91)90049-Z
  14. Dahan M, Nawrocki B, Elkaim R, Soell M, Bolcato-Bellemin A-L, Birembaut P, Tenenbaum H: Expression of matrix metalloproteinases in healthy and diseased human gingiva. J Clin Periodontol 2001;28:128-136. https://doi.org/10.1034/j.1600-051x.2001.028002128.x
  15. Huh JK, Kim HG, Ko JY: Magnetic resonance imaging of temporomandibular joint synovial fluid collection and disk morphology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:665-671. https://doi.org/10.1067/moe.2003.159
  16. Vihinen P, Kahari VM: Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 2002;99:157-166. https://doi.org/10.1002/ijc.10329
  17. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG: Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem 1991;266:7870-7875.
  18. Breckon JJ, Hembry RM, Reynolds JJ, Meikle MC: Identification of matrix metalloproteinases and their inhibitor in the articular disc of the craniomandibular joint of the rabbit. Arch Oral Biol 1996;41:315-322. https://doi.org/10.1016/0003-9969(95)00141-7
  19. Overall CM, Wrana JL, Sodek J: Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem 1989;264:1860-1869.
  20. Overall CM, Wrana JL, Sodek J: Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J Biol Chem 1991;266:14064-14071.
  21. Aimes RT, Quigley JP: Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem 1995;270:5872-5876. https://doi.org/10.1074/jbc.270.11.5872
  22. Murphy G, Cockett MI, Ward RV, Docherty AJ: Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J 1991;277:277-279. https://doi.org/10.1042/bj2770277
  23. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, Salvesen G, Nagase H: Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem 1990;194:721-730. https://doi.org/10.1111/j.1432-1033.1990.tb19462.x
  24. Ishimaru JI, Oguma Y, Goss AN: Matrix metalloproteinase and tissue inhibitor of metalloproteinase in serum and lavage synovial fluid of patients with temporomandibular joint disorders. Br J Oral Maxillofac Surg 2000;38:354-359. https://doi.org/10.1054/bjom.2000.0306
  25. Zardeneta G, Milam SB, Lee T, Schmitz JP: Detection and preliminary characterization of matrix metalloproteinase activity in temporomandibular joint lavage fluid. Int J Oral Maxillofac Surg 1998;27:397-403. https://doi.org/10.1016/S0901-5027(98)80072-6
  26. Sadowski T, Steinmeyer J: Effects of tetracyclines on the production of matrix metalloproteinases and plasminogen activators as well as of their natural inhibitors, tissue inhibitor of metalloproteinases-1 and plasminogen activator inhibitor-1. Inflamm Res 2001;50:175-182. https://doi.org/10.1007/s000110050742